Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,9261765,half-life,Each subject was treated with each of the three dapiprazole regimens in three different study sessions separated by at least 5 days (drug half-life in the eye is 5 hours).,Dose-response study of dapiprazole HCl in the reversal of mydriasis induced by 2.5% phenylephrine. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9261765/),h,5,17858,DB00298,Dapiprazole
,24847516,recoveries,The mean recoveries of dapiprazole from DBS and urine were 93.88 and 90.29% respectively.,Development of LC-MS/MS method for the determination of dapiprazole on dried blood spots and urine: application to pharmacokinetics. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24847516/),%,93.88,117476,DB00298,Dapiprazole
,24847516,recoveries,The mean recoveries of dapiprazole from DBS and urine were 93.88 and 90.29% respectively.,Development of LC-MS/MS method for the determination of dapiprazole on dried blood spots and urine: application to pharmacokinetics. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24847516/),%,90.29,117477,DB00298,Dapiprazole
,24847516,limits of detection,"The limits of detection and quantification were 0.30 and 1.10 ng/mL in DBS and 0.45 and 1.50 ng/mL in urine samples, respectively.",Development of LC-MS/MS method for the determination of dapiprazole on dried blood spots and urine: application to pharmacokinetics. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24847516/),[ng] / [ml],0.30,117478,DB00298,Dapiprazole
,24847516,limits of detection,"The limits of detection and quantification were 0.30 and 1.10 ng/mL in DBS and 0.45 and 1.50 ng/mL in urine samples, respectively.",Development of LC-MS/MS method for the determination of dapiprazole on dried blood spots and urine: application to pharmacokinetics. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24847516/),[ng] / [ml],1.10,117479,DB00298,Dapiprazole
,24847516,limits of detection,"The limits of detection and quantification were 0.30 and 1.10 ng/mL in DBS and 0.45 and 1.50 ng/mL in urine samples, respectively.",Development of LC-MS/MS method for the determination of dapiprazole on dried blood spots and urine: application to pharmacokinetics. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24847516/),[ng] / [ml],0.45,117480,DB00298,Dapiprazole
,24847516,limits of detection,"The limits of detection and quantification were 0.30 and 1.10 ng/mL in DBS and 0.45 and 1.50 ng/mL in urine samples, respectively.",Development of LC-MS/MS method for the determination of dapiprazole on dried blood spots and urine: application to pharmacokinetics. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24847516/),[ng] / [ml],1.50,117481,DB00298,Dapiprazole
